What we will do in a nutshell:
TRL 5 aerobic photobioreactor reliant on engineered Synechocystis strains to produce enantiopure L-lactic acid, which is the precursor of polylactate bioplastics, providing the best potential economic margin according to PHO, from CO2 and driven by solar radiation during daylight hours and/or LED radiation (e.g. during night-time hours). Operating the photobioreactor exploiting both solar and artificial light is enabled by the envisaged highly integrated processes’ scheme, which will power LEDs from low-price electricity derived from a biogas engine based cogeneration unit.
The main factors we want to capture in the concept design of the MF1 (arbitrarily ordered) are:
The ultimate goal is to design strains, encompassing metabolic engineering strategies that are predicted to lead to stable and robust production of the target compound Lactic acid at the highest titres and productivities possible.
This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 760994.
The content of this publication is the sole responsibility of the authors. The European Commission or its services cannot be held responsible for any use that may be made of the information it contains.